This Solicitation opportunity from Department Of Defense was posted on July 16, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
CLOBETASOL CREAM
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
Clobetasol Propionate Cream 0.05% in 60-gram unit dose tubes, supplied in treatment units (TU) with each TU equaling three units, is being procured under solicitation SPE2DP-26-T-4178 by the Department of Defense through DLA Troop Support Medical Supply Chain Pharm FSA. The contract requires delivery of 10 TU to Fort Stewart, Georgia, within 20 days of order placement under FOB destination terms, with all items subject to inspection and acceptance at the destination. The product must be stored at medical controlled room temperature and meet exact packaging and labeling standards per MIL-STD-2073-1E and the Medical Marking Standard No. 1, which supersedes MIL-STD-129 for all medical items. The item is regulated by the FDA, and bidders must provide full manufacturer and NDC information for verification, with no government identification allowed on non-accepted supplies. Shelf life is strictly 24 months, non-extendable, and items must be marked and preserved accordingly. The solicitation incorporates multiple FAR and DFARS clauses including those on trafficking in persons, employment eligibility, sustainable products, hazardous materials, safeguarding contractor information, and export control, with deviation authorizations applied throughout. Compliance with the Hazard Communication Standard is mandatory for labeling, and all deliveries must be invoiced via Wide Area Workflow. Offerors must hold a valid UEI and CAGE code, and socioeconomic status representations are required if claiming small business or other designated categories. The contract type is unspecified but is fixed-price, with no variance permitted in quantity (plus or minus zero percent). The product is sourced from Sun Pharmaceutical Industries, Inc. or Avkare LLC under NDC codes 51672-1258-03 and 42291-0076-60, respectively. All submissions must be electronically filed through the DIBBS portal by the deadline of July 22, 2026, and the award will be made under a simplified acquisition process governed by the DLA Master List technical and quality requirements in effect on the solicitation issue date.
General Info
Agency
NAICS
Place of Performance
BLDG 1509 WEST 6TH STREET, FORT STEWART, GA, 31314-5185, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
CLOBETASOL PROPIONATE CREAM, 0.05%, 60 GRAM, U/I TUBE, STORE AT MEDICAL
CONTROLLED ROOM TEMPERATURE.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
1 TU = 3 EA
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/
SUN PHARMACEUTICAL INDUSTRIES, INC. 0PUV4 P/N NDC51672-1258-03 AVKARE LLC 4QGW8 P/N NDC42291-0076-60
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017513491 0001 TU 10.000
NSN/MATERIAL:6505013877695
DELIVERY (IN DAYS):0020
SPE2DP-26-T-4178
SECTION B
PR: 7017513491 PRLI: 0001 CONT’D
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-387-7695 Quantity: 10 TU Purchase Request: 7017513491QTY: 10 Delivery: 20 days ADO
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS